AI assistant
ELI LILLY & Co — Director's Dealing 2024
Sep 12, 2024
29745_dirs_2024-09-12_365c0cf8-3779-478b-abf7-3a247a3cd55b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-09-10
Reporting Person: Skovronsky Daniel (EVP, CSO & Pres. LRL & LLY Imm)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-10 | Common Stock | G | 111 | — | Disposed | 123627 | Direct |
| 2024-09-11 | Common Stock | G | 5724 | — | Disposed | 117903 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 72359 | Indirect |
| Common Stock | 3257 | Indirect |
Footnotes
F1: Among other gift transactions, the reporting person transferred: (a) 2,359 shares of Eli Lilly and Company common stock to DMGCS Family Holdings LLC, which is a single-member limited liability company held and controlled solely by the reporting person's spouse as trustee of a trust for the benefit of the reporting person's spouse and children; and (b) 3,257 shares of Eli Lilly and Company common stock to the reporting person's spouse.
F2: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.